SCHEMBL5869443

SCHEMBL5869443

COC(=O)C(CC(C)C)NC(=O)NCc1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.75
ANPEP P15144 6/20 0.73
L3MBTL1 Q9Y468 2/20 0.70
MAPT P10636 1/20 0.70
PPID Q08752 1/20 0.62
ALDH1A1 P00352 2/20 0.61
CTSL P07711 1/20 0.60
CTSB P07858 1/20 0.60
CTSS P25774 1/20 0.60
CTSK P43235 1/20 0.60
LMNA P02545 1/20 0.60
PSMB5 P28074 1/20 0.58
POLB P06746 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C19 P33261 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8248836 1.00 ATM (0.75) ATMANPEPL3MBTL1MAPTPPID
SCHEMBL15623786 0.90 ANPEP (0.67) ATMANPEPL3MBTL1MAPTPPID
SCHEMBL4770883 0.87 ANPEP (0.79) ATMANPEPL3MBTL1MAPTALDH1A1
SCHEMBL4770866 0.87 ANPEP (0.79) ATMANPEPL3MBTL1MAPTALDH1A1
SCHEMBL24446776 0.87 ANPEP (0.67) ATMANPEPL3MBTL1MAPTPPID
SCHEMBL5870605 0.86 ANPEP (0.74) ATMANPEPPSMB5POLB
SCHEMBL2561481 0.86 ATM (1.00) ATMANPEPL3MBTL1MAPTALDH1A1
SCHEMBL10493865 0.86 ATM (1.00) ATMANPEPL3MBTL1MAPTALDH1A1
SCHEMBL28862820 0.85 ANPEP (0.68) ATMANPEPL3MBTL1MAPTALDH1A1
SCHEMBL28862821 0.85 ANPEP (0.68) ATMANPEPL3MBTL1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7045532-B2 ACE-2 modulating compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-05-16 US disclosed
US-6632830-B1 Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder MILLENNIUM PHARMACEUTICALS, INC. 2003-10-14 US disclosed